CClinicalTrials.gg
Sign In
CompletedNCT04539184Updated Nov 19, 2021

The Effectiveness and Cost-effectiveness of Motion Style Acupuncture Treatment (MSAT) for Acute Neck Pain: A Multi-center Randomized Controlled Trial

An interventional study of Motion Style Acupuncture Treatment (MSAT) and Acupuncture in Acute Neck Pain, sponsored by Jaseng Medical Foundation. Completed at 4 sites in Korea, Republic of. Open to participants aged 19 Years to 70 Years. Per ClinicalTrials.gov, last updated 2021-11-19.

Sponsored by Jaseng Medical Foundation · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
128
Allocation
Randomized
Ages
19 Years to 70 Years
Sex
All
01

Study summary

The investigators will evaluate the comparative effectiveness and safety of Motion Style Acupuncture Treatment (MSAT) therapy for acute neck pain compared to acupuncture.

Read the detailed description

This is a multi-center, randomized, controlled, comparative effectiveness clinical trial for acute neck pain. Motion style acupuncture requires a part of the patient's body to move passively or actively while acupuncture needles are retained.

02

Conditions studied

  • Acute Neck Pain

Browse trials for

03

In context

Neck Pain

1,232 studies on the registry are indexed under Neck Pain; 255 are open to participants now.

This study's enrollment of 128 is above the median of 52 across 1,004 interventional studies indexed under Neck Pain.

Browse Neck Pain studies →

Lead sponsor

Jaseng Medical Foundation is the lead sponsor of 67 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Neck pain onset or worsen within one month
  • VAS of neck pain on movement or at rest of 5 or higher
  • Age between 19 and 70 years old
  • Participants who wrote a informed consent

Exclusion criteria

Exclusion Criteria:

  • Participants who diagnosed with the serious disease that can cause pain (e.g. Migration of cancer reaching to spine, fracture of spine, dislocation of spine)
  • Progressive neurologic deficits or severe neurologic deficits
  • Participants who diagnosed with a soft tissue disease that can cause pain (Cancer, fibromyalgia, RA, or goat)
  • Chronic disease (e.g. Cardiovascular disease, kidney disease, dementia, diabetic neuropathy, or epilepsy)
  • Participants taking steroids, immunosuppressants, or psychotropic medication
  • Participants who could be inadequate or unsafe at acupuncture (e.g. Hemorrhagic disease, severe diabetes or taking anticoagulant drug)
  • Participants who took NSAIDs or acupuncture within 3 days
  • Participants who had undergone cervical surgery within 3 months
  • Participants who had a traffic accident within a month
  • Pregnant or women who planned to conceive
  • Participants who had participated in other clinical trial within 1 month, or have plan for participation in other trial within 6 months from enrollment
  • Participants who can not write informed consent
  • Participants who is difficult to participate in the trial according to investigator's decision
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
128 participants (actual)

Study arms

  • Experimental
    Motion Style Acupuncture treatment

    Motion Style Acupuncture treatment (2-3 times/week, 2 weeks)

    Other: Motion Style Acupuncture Treatment (MSAT)

  • Active comparator
    Acupuncture treatment

    Acupuncture treatment (2-3 times/week, 2 weeks)

    Other: Acupuncture

Interventions

  • OtherMotion Style Acupuncture Treatment (MSAT)

    MSAT required a part of the patient's body to move passively or actively while acupuncture needles are retained.

  • OtherAcupuncture

    General acupuncture

06

What researchers measure

Primary outcomes

  1. Visual Analogue Scale(VAS) on movement

    Minimum 0, Maximum 100. Higher values represent a worse outcome

    Time frame: Change from baseline VAS at 3 weeks

Secondary outcomes

  1. Visual Analogue Scale (VAS) on movement

    Minimum 0, Maximum 100. Higher values represent a worse outcome

    Time frame: Baseline(Week 1), Week 2, 3, 8

  2. Visual Analogue Scale (VAS) at rest

    Minimum 0, Maximum 100. Higher values represent a worse outcome

    Time frame: Baseline(Week 1), Week 2, 3, 8

  3. Numeric Rating Scale (NRS) on movement

    Minimum 0, Maximum 10. Higher values represent a worse outcome

    Time frame: Baseline(Week 1), Week 2, 3, 8

  4. Numeric Rating Scale (NRS) at rest

    Minimum 0, Maximum 10. Higher values represent a worse outcome

    Time frame: Baseline(Week 1), Week 2, 3, 8

  5. Vernon-Mior Neck Disability Index (NDI)

    Functional disability questionnaire

    Time frame: Baseline(Week 1), Week 2, 3, 8

  6. Northwick Park Neck Pain Questionnaire (NPQ)

    Functional disability questionnaire and Pain questionnaire

    Time frame: Baseline(Week 1), Week 2, 3, 8

  7. Patient Global Impression of Change (PGIC)

    Global, patient-reported outcome, Minimum 1, Maximum 7, Higher values represent a better outcome

    Time frame: Week 3, 8

  8. Range of movement (ROM) of flexion

    Range of movement of flexion

    Time frame: Baseline(Week 1), Week 2, 3, 8

  9. Range of movement (ROM) of extension

    Range of movement of extension

    Time frame: Baseline(Week 1), Week 2, 3, 8

  10. Range of movement (ROM) of Rt rotation

    Range of movement of Right rotation

    Time frame: Baseline(Week 1), Week 2, 3, 8

  11. Range of movement (ROM) of Lt rotation

    Range of movement of Left rotation

    Time frame: Baseline(Week 1), Week 2, 3, 8

  12. Range of movement (ROM) of Lt lateroflexion

    Range of movement of Left lateroflexion

    Time frame: Baseline(Week 1), Week 2, 3, 8

  13. Range of movement (ROM) of Rt lateroflexion

    Range of movement of Right lateroflexion

    Time frame: Baseline(Week 1), Week 2, 3, 8

  14. EQ-5D-5L

    Health-related quality of life questionnaire

    Time frame: Baseline(Week 1), 3, 8

  15. 12-item Short-Form Health Survey (SF-12)

    Health-related quality of life questionnaire

    Time frame: Baseline(Week 1), 3, 8

  16. EuroQol Visual Analogue Scale (EQ-VAS)

    Health-related quality of life questionnaire

    Time frame: Baseline(Week 1), 3, 8

  17. Adverse events

    Safety outcome

    Time frame: Time Frame: Baseline (Week 1), Week 2, 3, 8 (every visit)

  18. Drug Consumption

    Drug type and dose of prescribe for medicine or rescue medicine, and type and frequency of other treatments

    Time frame: Time Frame: Baseline (Week 1), Week 2, 3, 8 (every visit)

07

Study locations

4 sites
  • Jaseng Hospital of Korean Medicine
    Seoul, Gangnam-Gu 135-896, Korea, Republic of
  • Bucheon Jaseng Hospital of Korean Medicine
    Bucheon, Gyeonggi Province 14598, Korea, Republic of
  • Haeundae Jaseng Hospital of Korean Medicine
    Busan, Korea, Republic of
  • Daejeon Jaseng Hospital of Korean Medicine
    Daejeon, 35262, Korea, Republic of
08

References and documents

Publications

  • Kim D, Lee YJ, Park KS, Kim S, Seo JY, Cho HW, Ha IH. The effectiveness and cost-effectiveness of motion style acupuncture treatment (MSAT) for acute neck pain: A multi-center randomized controlled trial. Medicine (Baltimore). 2020 Oct 30;99(44):e22871. doi: 10.1097/MD.0000000000022871. PubMed 33126334 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 19, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04539184
Lead sponsor
Jaseng Medical Foundation
Responsible party
In-Hyuk Ha, KMD (Director, Jaseng Medical Foundation) — Principal investigator
First posted
Sep 4, 2020
Start date
Sep 10, 2020
Primary completion
Nov 18, 2021
Completion
Nov 18, 2021
Last update
Nov 19, 2021

Study contacts

In-Hyuk Ha, Dr.
principal investigator · Jaseng Medical Foundation

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Neck Pain→

Other studies from this sponsor

Jaseng Medical Foundation

Start the discussion